attana - sensor technologies

Attana featured in IPT

Attana featured in the latest issue of IPT - Talking Sense: A combined biochemical and cell-based biosensor is being developed to enable detailed interaction characterisation between biopharmaceutical molecules and target receptors on cell surfaces.

Stockholm, September 12, 2013 – Attana is featured in the latest issue (46) of IPT-Innovations in Pharmaceutical Technology. In the article "Talking Sense,"  Attana's founder, Teodor Aastrup explains how the Attana Cell 200 enables detailed interaction characterization between biopharmaceutical molecules and target receptors on cell surfaces. 

Click here to read the full article in IPT:

To learn more about Attana Contract Research Services and our label free cell-based biosensors, please visit www.attana.com or contact our sales department sales@attana.com.

 About Attana:

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences.